Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Soluble VEGF receptors.

C Hornig1, H A Weich

  • 1National Research Center for Biotechnology (GBF), Department of RDIF, Mascheroder Weg 1, 38124 Braunschweig, Germany.

Angiogenesis
|October 1, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medical graphics to improve patient understanding and anxiety in elderly and cognitively impaired patients scheduled for transcatheter aortic valve implantation (TAVI).

Clinical research in cardiology : official journal of the German Cardiac Society·2023
Same author

Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma.

Leukemia·2016
Same author

Integration of CD45-positive leukocytes into newly forming lymphatics of adult mice.

Histochemistry and cell biology·2016
Same author

2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (HZ52)--a novel type of 5-lipoxygenase inhibitor with favourable molecular pharmacology and efficacy in vivo.

British journal of pharmacology·2011
Same author

Lymphatics and inflammation.

Current medicinal chemistry·2009
Same author

Ectopic bone formation after implantation of a slow release system of polylactic acid and rhBMP-2.

Clinical oral implants research·2009
Same journal

Endothelial Notch1 drives multicellular remodelling during hyaloid vessel regression.

Angiogenesis·2026
Same journal

Endothelial protein C receptor and the endothelial progenitor paradigm: towards a functional definition at last.

Angiogenesis·2026
Same journal

Tumour endothelial cell reprogramming orchestrates angiocrine signalling to drive chemoresistance in breast cancer.

Angiogenesis·2026
Same journal

A possible microvascular vulnerability in carotid artery dissection: insights from nailfold capillaroscopy.

Angiogenesis·2026
Same journal

miR-150 controls developmental angiogenesis via ribosome biogenesis-dependent regulation of Notch signaling.

Angiogenesis·2026
Same journal

MCC links Wnt/PCP signaling to endothelial polarity and vascular remodeling.

Angiogenesis·2026
See all related articles

Soluble vascular endothelial growth factor (VEGF) receptors, particularly VEGFR-1, are key regulators of blood vessel formation. These receptors can be utilized to inhibit VEGF signaling and block tumor angiogenesis.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The three human vascular endothelial growth factor (VEGF) receptors (VEGFRs 1-3) are crucial for blood vessel formation (angiogenesis) and lymphatic vessel formation (lymphangiogenesis).
  • Soluble VEGF receptors possess high-affinity ligand-binding capabilities and are employed as experimental tools in various angiogenic models.
  • Recombinant soluble VEGF receptors can inhibit VEGF-mediated signal transduction, offering a strategy to block tumor angiogenesis.

Purpose of the Study:

  • To explore the role of soluble VEGF receptors as inhibitors of tumor angiogenesis.
  • To investigate the potential of recombinant receptor molecules in limiting VEGF availability.
  • To understand the regulatory function of naturally occurring soluble VEGFR-1 in VEGF bioavailability.

Main Methods:

Related Experiment Videos

  • Utilizing recombinant soluble VEGF receptor molecules.
  • Employing in vitro and in vivo angiogenic models.
  • Analyzing VEGF levels secreted by tumor and stromal cells.
  • Investigating the supernatant of endothelial cells for naturally occurring soluble VEGFR-1.

Main Results:

  • Soluble VEGF receptors effectively bind to VEGF ligands.
  • Recombinant receptor molecules demonstrate potential in inhibiting VEGF-mediated signaling and blocking tumor angiogenesis.
  • A naturally occurring soluble VEGFR-1 was identified in endothelial cell supernatant, suggesting a role in regulating VEGF availability.

Conclusions:

  • Soluble VEGF receptors are valuable tools for studying and potentially inhibiting angiogenesis.
  • Soluble VEGFR-1 appears to be a significant regulator of VEGF bioavailability.
  • Further research is needed to fully elucidate the physiological role of soluble VEGFR-1 in angiogenesis and lymphangiogenesis.